Nina E. Weisser

519 total citations
12 papers, 299 citations indexed

About

Nina E. Weisser is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Nina E. Weisser has authored 12 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Nina E. Weisser's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and CAR-T cell therapy research (4 papers). Nina E. Weisser is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and CAR-T cell therapy research (4 papers). Nina E. Weisser collaborates with scholars based in Canada, United States and Ireland. Nina E. Weisser's co-authors include J. Christopher Hall, Grant Wickman, R. H. Davies, David R. Bundle, Robert J. Woods, Margaret A. Johnson, Kurt C. Almquist, Surjit B. Dixit, Libin Abraham and Neil C. Josephson and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Biotechnology Advances.

In The Last Decade

Nina E. Weisser

11 papers receiving 293 citations

Peers

Countries citing papers authored by Nina E. Weisser

Since Specialization

Citations

This map shows the geographic impact of Nina E. Weisser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina E. Weisser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina E. Weisser more than expected).

Fields of papers citing papers by Nina E. Weisser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina E. Weisser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina E. Weisser. The network helps show where Nina E. Weisser may publish in the future.

Co-authorship network of co-authors of Nina E. Weisser

This figure shows the co-authorship network connecting the top 25 collaborators of Nina E. Weisser. A scholar is included among the top collaborators of Nina E. Weisser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina E. Weisser. Nina E. Weisser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Abstract 3503: ZW171, a differentiated 2+1 T cell-engaging bispecific antibody with antitumor activity in a range of mesothelin-expressing cancers 2025 ·Cancer Research ·Nicole Afacan, (unknown), (unknown), Maya C. Poffenberger, Chayne L. Piscitelli, (unknown), Nina E. Weisser	1
2	Abstract 6716: DLL3 TriTCE Co-Stim: A next generation trispecific T cell engager with integrated CD28 costimulation for the treatment of DLL3-expressing cancers 2024 ·Cancer Research ·(unknown), Desmond W. M. Lau, (unknown), (unknown), (unknown), Mariana C. Rocha, (unknown), John H. Zhang, (unknown), Nichole Escalante, (unknown), (unknown), Chayne L. Piscitelli, Paul A. Moore, (unknown), Nina E. Weisser	1
3	Abstract 6719: TriTCE Co-Stim: A next generation trispecific T cell engager platform with integrated CD28 costimulation, engineered to improve responses in the treatment of solid tumors 2024 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Maya C. Poffenberger, (unknown), (unknown), Alexandra Livernois, Chayne L. Piscitelli, Nicole Afacan, Paul A. Moore, Nina E. Weisser, (unknown)	0
4	Abstract 2926: PROTECTTM, a novel trispecific antibody masking platform with integrated immune modulation displays unique activity and differentiated modes of action 2023 ·Cancer Research ·(unknown), (unknown), Nichole Escalante, (unknown), Bryant Harbourne, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kevin G. Haworth, (unknown), (unknown), Surjit B. Dixit, Nina E. Weisser, (unknown)	1
5	Abstract 5121: TriTCE Co-stim, next generation costimulatory trispecific T cell engagers for the treatment of solid tumors 2023 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), Nichole Escalante, (unknown), (unknown), (unknown), (unknown), David N. Douda, Chayne L. Piscitelli, Nicole Afacan, (unknown), Nina E. Weisser	2
6	Abstract 1005: The bispecific antibody zanidatamab's (ZW25's) unique mechanisms of action and durable anti-tumor activity in HER2-expressing cancers 2021 ·Cancer Research ·Nina E. Weisser, Grant Wickman, Libin Abraham, (unknown), Bryant Harbourne, (unknown), (unknown), Peter W. Y. Chan, Duncan Browman, Michael R. Gold, Neil C. Josephson, Surjit B. Dixit, (unknown)	17
7	AlbuCORE: an albumin-based molecular scaffold for multivalent biologics design 2020 ·mAbs ·Mário Sanches, I. D’Angelo, María Jaramillo, Jason Baardsnes, John C. Zwaagstra, (unknown), Ian C. Schoenhofen, Mauro Acchione, (unknown), Grant Wickman, Nina E. Weisser, David Poon, Gordon Ng, Surjit B. Dixit	3
8	Abstract 31: Preclinical development of a novel biparatopic HER2 antibody with activity in low to high HER2 expressing cancers 2017 ·Cancer Research ·Nina E. Weisser, Grant Wickman, R. H. Davies, (unknown)	31
9	Molecular Recognition of Candida albicans (1→2)-β-Mannan Oligosaccharides by a Protective Monoclonal Antibody Reveals the Immunodominance of Internal Saccharide Residues 2012 ·Journal of Biological Chemistry ·Margaret A. Johnson, (unknown), Nina E. Weisser, Robert J. Woods, David R. Bundle	35
10	Complexes with anti-epitope tag IgGs improve the therapeutic potential of epitope-tagged antibody fragments 2010 ·Molecular Immunology ·Xuemei Xie, Nina E. Weisser, Michael D. McLean, J. Christopher Hall	2
11	Applications of single-chain variable fragment antibodies in therapeutics and diagnostics 2009 ·Biotechnology Advances ·Nina E. Weisser, J. Christopher Hall	198
12	A rAb screening method for improving the probability of identifying peptide mimotopes of carbohydrate antigens 2007 ·Vaccine ·Nina E. Weisser, Kurt C. Almquist, J. Christopher Hall	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact